Evaluation of four commercially available Epstein-Barr virus enzyme immunoassays with an immunofluorescence assay as the reference method

Clinical and Diagnostic Laboratory Immunology

Volumn 10, Issue 1, 2003, Pages 78-82

  Gärtner, Barbara C ^a   Hess, Ralf D ^b   Bandt, Dirk ^c   Kruse, Alexander ^c   Rethwilm, Axel ^c   Roemer, Klaus ^a   Mueller Lantzsch, Nikolaus ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b HiSS Diagnostics GmbH   (Germany)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS ANTIGEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; VIRUS CAPSID ANTIGEN;

ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CROSS REACTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; ENZYME IMMUNOASSAY; EPSTEIN BARR VIRUS; EVALUATION; HERPES VIRUS; HUMAN; IMMUNOCOMPETENCE; IMMUNOFLUORESCENCE TEST; INFECTIOUS MONONUCLEOSIS; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PERFORMANCE; PRIORITY JOURNAL; REFERENCE VALUE; SERODIAGNOSIS; VIRUS CAPSID; VIRUS INFECTION;

ANTIGENS, VIRAL; CAPSID PROTEINS; CROSS REACTIONS; DIAGNOSTIC ERRORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPSTEIN-BARR VIRUS INFECTIONS; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; REAGENT KITS, DIAGNOSTIC;

EID: 0037246861     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.10.1.78-82.2003     Document Type: Article

References (17)

1. Bakeman, R., and J. M. Gottman. 1997. Observing interaction: an introduction to sequential analysis, 2nd edition. Cambridge University Press, New York, N.Y.
2. Bauer, G. 2001. Simplicity through complexity: immunoblot with recombinant antigens as the new gold standard in Epstein-Barr virus serology. Clin. Lab. 47:223-230.
3. Buisson, M., B. Fleurent, M. Mak, P. Morand, L. Chan, A. Ng, M. Guan, D. Chin, and J. M. Seigneurin. 1999. Novel immunoblot assay using four recombinant antigens for diagnosis of Epstein-Barr virus primary infection and reactivation. J. Clin. Microbiol. 37:2709-2714.
4. Debyser, Z., M. Reynders, P. Goubau, and J. Desmyter. 1997. Comparative evaluation of three ELISA techniques and an indirect immunofluorescence assay for the serological diagnosis of Epstein-Barr virus infection. Clin. Diagn. Virol. 8:71-81,
5. Farber, I., W. Hinderer, M. Rothe, D. Lang, H. H. Sonneborn, and P. Wutzler. 2001. Serological diagnosis of Epstein-Barr virus infection by novel ELISAs based on recombinant capsid antigens p23 and p18. J. Med. Virol. 63:271-276.
6. Field, P. R., and D. E. Dwyer. 1996. Difficulties with the serologic diagnosis of infectious mononucleosis: a review of the RCPA quality assurance programs. Pathology 28:270-276.
7. Gärtner, B. C., J. M. Fischinger, K. Roemer, M. Mak, B. Fieurent, and N. Mueller-Lantzsch. 2001. Evaluation of a recombinant line blot for diagnosis of Epstein-Barr virus compared with ELISA, using immunofluorescence as reference method. J. Virol. Methods 93:89-96.
8. Gärtner, B. C., K. Kortmann, M. Schafer, N. Mueller-Lantzsch, U. Sester, H. Kaul, and H. Pees. 2000. No correlation in Epstein-Barr virus reactivation between serological parameters and viral load, J. Clin. Microbiol. 38:2458.
9. Hille, A., K. Klein, S. Baumler, F. A. Grasser, and N. Mueller-Lantzsch. 1993. Expression of Epstein-Barr virus nuclear antigens 1, 2A and 2B in the baculovirus expression system: serological evaluation of human antibodies to these proteins. J. Med. Virol. 39:233-241.
10. Middeldorp, J. M., and P. Herbrink. 1988. Epstein-Barr virus specific marker molecules for early diagnosis of infectious mononucleosis. J. Virol. Methods 21:133-146.
11. Rhodes, G. H., J. R. Valbracht, M. D. Nguyen, and J. H. Vaughan. 1997. The p542 gene encodes an autoantigen that cross-reacts with EBNA-1 of the Epstein-Barr virus and which may be a heterogeneous nuclear ribonucleo-protein. J. Autoimmun. 10:447-454.
12. Svahn, A., M. Magnusson, L. Jagdahl, L. Schloss, G. Kahlmeter, and A. Linde. 1997. Evaluation of three commercial enzyme-linked immunosorbent assays and two latex agglutination assays for diagnosis of primary Epstein-Barr virus infection. J. Clin. Microbiol. 35:2728-2732.
13. Vaughan, J. H., J. R. Valhracht, M. D. Nguyen, H. H. Handley, R. S. Smith, K. Patrick, and G. H. Rhodes. 1995. Epstein-Barr virus-induced autoimmune responses. I. Immunoglobulin M autoantibodies to proteins mimicking and not mimicking Epstein-Barr virus nuclear antigen-1. J. Clin. Investig. 95:1306-1315.
14. Weber, B., M. Brunner, W. Preiser, and H. W. Doerr. 1996. Evaluation of 11 enzyme immunoassays for the detection of immunoglobulin M antibodies to Epstein-Barr virus. J. Virol. Methods 57:87-93.
15. Wiedbrauk, D. L., and S. Bassin. 1993. Evaluation of five enzyme immunoassays for detection of immunoglobulin M antibodies to Epstein-Barr virus viral capsid antigens. J. Clin. Microbiol. 31:1339-1341.
16. Winkelspecht, B., F. Grasser, H. W. Pees, and N. Mueller-Lantzsch. 1996. Anti-EBNA1/anti-EBNA2 ratio decreases significantly in patients with progression of HIV infection. Arch. Virol. 141:857-864.
17. Winkelspecht, B., N. Mueller-Lantzsch, and H. Kohler. 1997. Serological evidence for reactivation of EBV infection due to uraemic immunodeficiency. Nephrol. Dial. Transplant. 12:2099-2104.